Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
The inspection classification was determined by the agency as Voluntary Action Indicated
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Meningitis still affects more than 2.5 million people globally each year
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
Subscribe To Our Newsletter & Stay Updated